Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Chromatin factor YY1 controls fetal hematopoietic stem cell migration and engraftment in mice
Sahitya Saka, … , Michael L. Atchison, Xuan Pan
Sahitya Saka, … , Michael L. Atchison, Xuan Pan
Published July 30, 2025
Citation Information: J Clin Invest. 2025;135(19):e188140. https://doi.org/10.1172/JCI188140.
View: Text | PDF
Research Article Development Hematology

Chromatin factor YY1 controls fetal hematopoietic stem cell migration and engraftment in mice

  • Text
  • PDF
Abstract

The fetal liver is the primary site of hematopoietic stem cell (HSC) generation during embryonic development. However, the molecular mechanisms governing the transition of hematopoiesis from the fetal liver to the BM remain incompletely understood. Here, we identify the mammalian Polycomb Group protein Yin Yang 1 (YY1) as a key regulator of this developmental transition. Conditional deletion of Yy1 in the hematopoietic system during fetal development results in neonatal lethality and depletion of the fetal HSC pool. YY1-deficient fetal HSCs exhibit impaired migration and fail to engraft in the adult BM, thereby losing their ability to reconstitute hematopoiesis. Transcriptomic analysis reveals that Yy1 KO disrupts genetic networks controlling cell motility and adhesion in fetal hematopoietic stem and progenitor cells (HSPCs). Notably, YY1 does not directly bind the promoters of most dysregulated genes. Instead, it modulates chromatin accessibility at regulatory loci, orchestrating broader epigenetic programs essential for HSPC migration and adhesion. Together, these findings establish YY1 as a critical epigenetic regulator of fetal HSC function and provide a mechanistic framework to further decipher how temporal epigenomic configurations determine HSC fetal-to-adult transition during development.

Authors

Sahitya Saka, Zhanping Lu, Yinghua Wang, Peng Liu, Deependra K. Singh, Junki P. Lee, Carmen G. Palii, Tyler R. Alvarez, Anna L.F.V. Assumpção, Xiaona You, Jing Zhang, Marjorie Brand, Michael L. Atchison, Xuan Pan

×

Figure 1

Yy1 deletion during embryonic hematopoiesis leads to neonatal death in mice.

Options: View larger image (or click on image) Download as PowerPoint

Yy1 deletion during embryonic hematopoiesis leads to neonatal death in ...
(A) Schematic illustration of the Yy1 locus. The conditional Yy1 allele (Yy1fl) was constructed by inserting a pair of loxP sites flanking exon 1 at the promoter region, which is excised in the presence of Cre recombinase expression. (B) Illustration of breeding strategy to generate Yy1fl/fl Vav-Cre fetuses. (C) PCR to detect YY1 deletion efficiency in total FL cells. Primers 1 and 2 detect Yy1fl. Primers 1 and 4 detect Yy1Δ. Primers 3 and 4 detect both Yy1fl and Yy1Δ. Mixed primers 1, 2, and 4 showed the relative primer efficiency. (D) The mRNA expression of Yy1 gene in the LSK cells of E14.5 Yy1fl/fl Vav-Cre fetus as compared with Yy1fl/fl littermates. (E) Kaplan-Meier survival curve of Yy1fl/fl and Yy1fl/fl Vav-Cre mice. (F) A representative photo of Yy1fl/fl Vav-Cre and Yy1fl/fl neonates around 24 hours after birth. (G) Body weight, (H) spleen/body weight, and (I) liver/body ratios of Yy1fl/fl Vav-Cre and Yy1fl/fl mice. (J) Images of blood smears and histopathology of BM (K) and liver (L) of Yy1fl/fl Vav-Cre and Yy1fl/fl mice. (J–L) Scale bar: 50 μm. Number of mice = n; graphs show mean ± SD, *P < 0.05, ****P < 0.0001, by unpaired 2-tailed Student’s t test (D and G–I) and simple survival curve analysis (Kaplan-Meier) (E).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts